This inventor holds 1 USPTO granted patent and 8 published patent applications. Top assignee: Seagen Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Ryan Lyski
Introduction
Ryan Lyski is a notable inventor based in Lynnwood, WA (US). He has made significant strides in the field of biotechnology, particularly in cancer treatment. His work focuses on developing novel therapeutic agents that can enhance the efficacy of cancer therapies.
Latest Patents
Ryan Lyski holds a patent for "Anti-PD-L1 antibodies and antibody-drug conjugates." This patent provides innovative methods for using anti-PD-L1 antibodies and antibody-drug conjugates to treat cancer. His contributions in this area are crucial for advancing cancer treatment options.
Career Highlights
Ryan is currently employed at Seagen Inc., a leading biotechnology company specializing in cancer therapies. His role at Seagen allows him to work on cutting-edge research and development projects that aim to improve patient outcomes.
Collaborations
Ryan has collaborated with talented individuals such as Byron Hua Kwan and Heather Van Epps. These partnerships enhance the research and development process, leading to more effective cancer treatments.
Conclusion
Ryan Lyski's innovative work in developing anti-PD-L1 antibodies and antibody-drug conjugates represents a significant advancement in cancer therapy. His contributions, along with his collaborations, are paving the way for new treatment options that could benefit many patients in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile